Vulnerability · CVE-2025-54551
Synapse Mobility 8.0, 8.0.1, 8.0.2, 8.1, and 8.1.1 contain a privilege escalation vulnerability through external control of Web parameter.
Published Aug 20, 2025 · catalog updated Aug 20, 2025 · FUJIFILM Healthcare Americas Corporation Synapse Mobility
Last checked Oct 26, 2026. A connected source was read within the last 7 days.
Check if you run it
No confirmed exploitation is on record for CVE-2025-54551. EPSS is 0.25%. Act only if a listed version of FUJIFILM Healthcare Americas Corporation Synapse Mobility is installed.
Gaps on this record
- No vendor fix or required action is stored. Compare the linked advisory before you change production.
- Severity
- Medium5.3
- Known exploitation
- Not in CISA/VulnCheck KEV
- EPSS
- 0.25%
- Remediation
- Vendor / distro source
- Affected products
- vendor FUJIFILM Healthcare Americas Corporation Synapse Mobility and 8.1.1
Synapse Mobility 8.0, 8.0.1, 8.0.2, 8.1, and 8.1.1 contain a privilege escalation vulnerability through external control of Web parameter. If exploited, a user of the product may escalate the privilege and access data that the user do not have permission to view by altering the parameters of the search function.
Are you affected?
Enter the version you run. The result uses only the ranges stored on this record.
The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.
- vendor FUJIFILM Healthcare Americas Corporation Synapse Mobility and 8.1.1and 8.1.1
How to fix CVE-2025-54551
No stored fix
No vendor fix text is stored. Use the linked advisory before you change production.
Version check
Seen in and 8.1.1
Advisory
Open the cve_org record and follow its fix.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
No confirmed exploitation is on record for CVE-2025-54551. EPSS is 0.25%. Act only if a listed version of FUJIFILM Healthcare Americas Corporation Synapse Mobility is installed.
Which versions are affected?
Compare what you have installed with FUJIFILM Healthcare Americas Corporation Synapse Mobility and 8.1.1 and 8.1.1. Compare the installed version with the linked vendor advisory before you change production.
What should an analyst verify?
No weakness class is stored. EPSS 0.25%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Code
The project this record applies to. Exploit listings stay in References.
No public source repository is identified for this product.
Timeline
Detection, updates, and resolution for this record.
Aug 20, 2025 · EUVD
Detected
Synapse Mobility 8.0, 8.0.1, 8.0.2, 8.1, and 8.1.1 contain a privilege escalation vulnerability through external control of Web parameter. If exploited, a user of the product may escalate the privilege and access data that the user do not have permission to view by altering the parameters of the search function.
Aug 20, 2025 · EUVD
Updated
Synapse Mobility 8.0, 8.0.1, 8.0.2, 8.1, and 8.1.1 contain a privilege escalation vulnerability through external control of Web parameter. If exploited, a user of the product may escalate the privilege and access data that the user do not have permission to view by altering the parameters of the search function.
Sources
- CVE.orgVulnerability recordCVE-2025-54551
Official CVE identifier
cve.org - FIRST EPSSExploitation probabilityCVE-2025-54551
30-day exploitation probability 0.25%
first.org - EUVDVulnerability recordEUVD-2025-25378
Synapse Mobility 8.0, 8.0.1, 8.0.2, 8.1, and 8.1.1 contain a privilege escalation vulnerability through external control of Web parameter. If exploited, a user of the product may escalate the privilege and access data that the user do not have permission to view by altering the p
euvd.enisa.europa.eu
References
Freshness
Last verified in this catalog Oct 26, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.
- FIRST EPSSOct 23, 2026
- CVE.orgOct 22, 2026
- EUVDOct 22, 2026